GE HealthCare Technologies Inc. has unveiled ambitious plans to enhance its artificial intelligence (AI) collaboration with Mass General Brigham’s commercial AI arm, Mass General Brigham AI. This strategic move aims to embed medical imaging foundation models into their AI research initiatives, prioritizing responsible AI practices.
Since committing to a decade-long exploration of AI applications in diagnostic and treatment landscapes back in 2017, the synergy between these pioneers has burgeoned. Now, with their latest endeavor, GE HealthCare is poised to fortify its footing in the realm of AI innovations, especially in the Imaging sector.
The Impact of the Collaboration
Conventional AI integration in healthcare typically necessitates retraining models to suit unique patient demographics and hospital environments, bringing about cost escalation and operational complexities that impede widespread AI adoption. However, by harnessing foundation models, GE HealthCare asserts that a sea change awaits the healthcare horizon, promising enhanced workflow efficiency and diagnostic accuracy.
These foundation models are lauded as trustworthy pillars for tailoring AI solutions to the healthcare domain, fueling optimism toward streamlined AI-fueled innovations that cater to patient well-being. In infusing responsible AI norms into this trajectory, GE HealthCare aims to steer the course of digital and AI evolution, crafting technologies that uphold patient safety, privacy, and equity.
Echoing this sentiment, Mass General Brigham foresees foundation models as the catalysts to a more efficient, accessible, and equitable healthcare environment for all stakeholders.
Market Dynamics
Per a report by Precedence Research, the global AI in healthcare market notched $15.1 billion in 2022 and is poised to soar past $187.95 billion by 2030, reflecting a compound annual growth rate (CAGR) of 37%. With digital healthcare adoption on the ascent and hospital patient volumes swelling, the market teems with promise.
Given this propitious landscape, the renewed collaboration is set to propel GE HealthCare’s global standing, harnessing the AI wave to drive business growth.
Recent AI Advancements
In a bid to showcase its AI-enabled medical devices and digital solutions, GE HealthCare recently took center stage at the Health Information and Management Systems Society Global Health Conference and Exhibition in Orlando, FL.
Moreover, its AI models demonstrated prowess by accurately predicting patient responses to immunotherapies, a breakthrough study hailed for its clinical acumen in gauging the efficacy and toxicity of cancer immunotherapy.
Additionally, GE HealthCare disclosed strides in its ultrasound division with the launch of the advanced LOGIQ ultrasound portfolio, featuring cutting-edge AI tools aimed at meeting the evolving needs of healthcare providers with seamless imaging, optimized workflow, and innovative digital solutions.
Financial Standing
Despite the healthcare sector’s challenges, GE HealthCare’s shares have surged by 15.3% over the past year, marginally outpacing the industry drop of 16.2%. Against the S&P 500’s 30% hike in the same period, GE HealthCare has showcased resilience.
Image Source: Zacks Investment Research
Zacks Rank & Key Insights
GE HealthCare currently holds a Zacks Rank #3 (Hold), surfacing as a stable player in the expansive medical landscape.
Other noteworthy stocks in the broader medical arena, such as DaVita Inc., Cardinal Health, Inc., and Cencora, Inc., have displayed robust growth potential, each bearing a unique value proposition that beckons investor attention.
With DaVita conquering a Zacks Rank #1 (Strong Buy), and both Cardinal Health and Cencora positioned at Zacks Rank #2, the medical sector teems with possibilities for astute investors looking to navigate the market terrain.
For more information, please visit Zacks.com.
